FR08C0024I2 - - Google Patents

Info

Publication number
FR08C0024I2
FR08C0024I2 FR08C0024C FR08C0024C FR08C0024I2 FR 08C0024 I2 FR08C0024 I2 FR 08C0024I2 FR 08C0024 C FR08C0024 C FR 08C0024C FR 08C0024 C FR08C0024 C FR 08C0024C FR 08C0024 I2 FR08C0024 I2 FR 08C0024I2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR08C0024C
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8870899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR08C0024(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of FR08C0024I1 publication Critical patent/FR08C0024I1/fr
Application granted granted Critical
Publication of FR08C0024I2 publication Critical patent/FR08C0024I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR08C0024C 2001-12-21 2008-06-05 Active FR08C0024I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116747A FR2833841B1 (fr) 2001-12-21 2001-12-21 Gel comprenant au moins un retinoide et du peroxyde de benzoyle
PCT/FR2002/004233 WO2003055472A1 (fr) 2001-12-21 2002-12-09 Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Publications (2)

Publication Number Publication Date
FR08C0024I1 FR08C0024I1 (fr) 2008-07-18
FR08C0024I2 true FR08C0024I2 (fr) 2009-11-20

Family

ID=8870899

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0116747A Expired - Fee Related FR2833841B1 (fr) 2001-12-21 2001-12-21 Gel comprenant au moins un retinoide et du peroxyde de benzoyle
FR08C0024C Active FR08C0024I2 (fr) 2001-12-21 2008-06-05

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR0116747A Expired - Fee Related FR2833841B1 (fr) 2001-12-21 2001-12-21 Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Country Status (22)

Country Link
EP (1) EP1458369B1 (fr)
JP (2) JP4889922B2 (fr)
KR (1) KR101014586B1 (fr)
CN (1) CN1329025C (fr)
AR (1) AR038026A1 (fr)
AT (1) ATE347354T1 (fr)
AU (2) AU2002364437B2 (fr)
BR (1) BRPI0214264B8 (fr)
CA (1) CA2466321C (fr)
CY (1) CY1107583T1 (fr)
DE (2) DE122008000041I1 (fr)
DK (1) DK1458369T3 (fr)
ES (1) ES2275948T3 (fr)
FR (2) FR2833841B1 (fr)
HU (1) HU230439B1 (fr)
MX (1) MXPA04005918A (fr)
PL (1) PL220838B1 (fr)
PT (1) PT1458369E (fr)
RU (1) RU2320327C2 (fr)
SI (1) SI1458369T1 (fr)
WO (1) WO2003055472A1 (fr)
ZA (1) ZA200403759B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
EP1813312A3 (fr) * 2002-09-05 2010-03-24 Galderma Research & Development Composition de dépigmentation pour la peau comportant de l'adapalène et au moins un agent de dépigmentation
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
WO2006053006A2 (fr) * 2004-11-09 2006-05-18 Imaginative Research Associates, Inc. Solutions de retinoides et formulations preparees a partir de ces dernieres
WO2007015243A2 (fr) 2005-08-02 2007-02-08 Sol-Gel Technologies Ltd. Revetement par un oxyde metallique d'ingredients hydroinsolubles
FR2889662B1 (fr) * 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
CA2616915A1 (fr) * 2005-09-02 2007-05-10 Isabelle Pelisson Composition de depigmentation destinee a la peau et comprenant de l'adapalene, au moins un agent de depigmentation et au moins un agent anti-inflammatoire
FR2890314B1 (fr) * 2005-09-02 2009-03-20 Galderma Res & Dev Compositiondepigmentante de la peau comprenant de l'adapalene au moins un agent depigmentant et au moins un agent anti-inflammatoire
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Res Australia Pty Ltd gel de suspensão espumante
FR2901139B1 (fr) * 2006-05-17 2009-03-20 Galderma Res & Dev S N C Snc Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations
CA2656451C (fr) * 2006-07-13 2015-01-27 Galderma Research & Development Composition comprenant un retinoide et du peroxyde de benzoyle
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
FR2903604B1 (fr) 2006-07-13 2008-09-05 Galderma Res & Dev S N C Snc Composition comprenant un retinoide et du peroxyde de benzoyle
US8080537B2 (en) 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
FR2909000B1 (fr) 2006-11-28 2009-02-06 Galderma Res & Dev S N C Snc Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations.
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) * 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
EP2114392B1 (fr) * 2007-01-30 2015-06-10 Galderma Research & Development Utilisation d'adapalène et de peroxyde de benzoyle dans le traitement à long terme de l'acné vulgaire
US20100047357A1 (en) * 2007-02-01 2010-02-25 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
EP1967180A1 (fr) * 2007-03-06 2008-09-10 Almirall Hermal GmbH Composition topique contenant un agoniste du recepteur de rétinoides
FR2916975B1 (fr) * 2007-06-11 2009-09-04 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
EP2065032A1 (fr) * 2007-11-27 2009-06-03 Galderma Research & Development Procédé pour la production de gels d'adapalène
EP2224908B1 (fr) * 2007-11-30 2017-11-01 Galderma Research & Development Compositions comprenant au moins un derive de l'acide naphtoïque, du peroxyde de benzoyle et au moins un agent filmogene.
ES2773931T3 (es) 2008-06-05 2020-07-15 Bausch Health Ireland Ltd Formulaciones farmacéuticas tópicas que contienen una baja concentración de peróxido de benzoílo en suspensión en agua y un solvente orgánico miscible en agua
EP3205355A1 (fr) * 2008-11-07 2017-08-16 KLOX Technologies, Inc. Combinaison d'un oxydant et d'un photoactivateur
US9682031B2 (en) 2009-10-07 2017-06-20 Tagra Biotechnologies Ltd. Microcapsules comprising benzoyl peroxide and topical compositions comprising them
RU2572693C2 (ru) * 2009-10-21 2016-01-20 Дау Фармасьютикал Сайенсиз, Инк. Способ смачивания порошка, содержащего пероксид бензоила
MX2012008871A (es) 2010-02-09 2012-08-31 Galderma Res & Dev Composicion dermatologica que comprende combinacion de adapaleno y peroxido de benzoilo para el tratamiento del acne en poblacion no caucasica con reduccion de hiperpigmentacion post-inflamatoria.
FR2969491B1 (fr) * 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
FR2969492B1 (fr) * 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
US8563535B2 (en) 2011-03-29 2013-10-22 Kamal Mehta Combination composition comprising benzoyl peroxide and adapalene
EP2854791A1 (fr) 2012-05-25 2015-04-08 Galderma Research & Development Traitement d'acne vulgaris modéré chez un préadolescent
US10610594B2 (en) * 2012-11-13 2020-04-07 Galderma S.A. BPO wash gel composition
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
EP3082785A1 (fr) 2013-12-19 2016-10-26 Galderma Research & Development Régime de traitement pour traiter des maladies liées à une acné sévère
AU2015239688B2 (en) 2014-04-01 2020-06-25 Galderma Research & Development Combination of adapalene and benzoyl peroxide for treating acne scars
MA40179B1 (fr) 2014-07-25 2020-10-28 Galderma Res & Dev Combinaison d'adapalène et de peroxyde de benzoyle pour le traitement de l'acné sévère
MX2018002176A (es) * 2015-08-20 2018-06-15 Sol Gel Tech Ltd Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.
WO2018080284A1 (fr) * 2016-10-31 2018-05-03 (주)동구바이오제약 Composition pharmaceutique destinée à améliorer la biodisponibilité d'un médicament pour le traitement de l'acné
CN106729722B (zh) * 2016-11-21 2020-05-12 成都山信药业有限公司 一种制备稳定复方制剂的方法及复方制剂
SG11202111028YA (en) * 2019-04-04 2021-11-29 Galderma Hoding Sa Isopropylcarbonate benzoyl peroxide compositions and methods of use
WO2023112664A1 (fr) * 2021-12-14 2023-06-22 ロート製薬株式会社 Composition pharmaceutique pour application externe contenant du peroxyde de benzoyle

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
US4189501A (en) * 1977-10-07 1980-02-19 A. H. C. Pharmacal, Inc. Composition and method for the treatment of acne
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
FR2628319B1 (fr) * 1988-03-09 1990-12-07 Oreal Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de sels d'ammonium quaternaires
CZ90494A3 (en) * 1991-10-16 1994-07-13 Richardson Vicks Skin care preparation having the form of aqueous gel
US5470884A (en) * 1994-05-19 1995-11-28 Procter & Gamble Anti-acne compositions
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
CN100387225C (zh) * 1999-12-20 2008-05-14 汉高两合股份公司 稠化体系的制片方法
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle

Also Published As

Publication number Publication date
MXPA04005918A (es) 2004-11-01
FR08C0024I1 (fr) 2008-07-18
JP4889922B2 (ja) 2012-03-07
RU2320327C2 (ru) 2008-03-27
CN1329025C (zh) 2007-08-01
BR0214264A (pt) 2004-09-21
AU2008246274B2 (en) 2011-05-19
HUP0500006A2 (en) 2006-08-28
CN1607946A (zh) 2005-04-20
AR038026A1 (es) 2004-12-22
PT1458369E (pt) 2007-03-30
SI1458369T1 (sl) 2007-04-30
FR2833841B1 (fr) 2005-07-22
CA2466321A1 (fr) 2003-07-10
DK1458369T3 (da) 2007-04-10
JP2005513146A (ja) 2005-05-12
WO2003055472A1 (fr) 2003-07-10
CY1107583T1 (el) 2013-03-13
FR2833841A1 (fr) 2003-06-27
DE60216634D1 (de) 2007-01-18
JP2011037904A (ja) 2011-02-24
HU230439B1 (hu) 2016-06-28
AU2008246274A1 (en) 2008-12-11
DE60216634T2 (de) 2007-09-27
AU2002364437B2 (en) 2008-08-21
KR101014586B1 (ko) 2011-02-16
DE122008000041I1 (de) 2008-11-20
KR20050016290A (ko) 2005-02-21
HUP0500006A3 (en) 2009-09-28
PL372270A1 (en) 2005-07-11
AU2002364437A1 (en) 2003-07-15
EP1458369A1 (fr) 2004-09-22
CA2466321C (fr) 2011-11-08
BRPI0214264B1 (pt) 2017-04-18
EP1458369B1 (fr) 2006-12-06
ES2275948T3 (es) 2007-06-16
BRPI0214264B8 (pt) 2021-05-25
RU2004122429A (ru) 2005-03-20
PL220838B1 (pl) 2016-01-29
JP5478468B2 (ja) 2014-04-23
ATE347354T1 (de) 2006-12-15
ZA200403759B (en) 2005-11-30

Similar Documents

Publication Publication Date Title
BE2022C531I2 (fr)
BE2022C502I2 (fr)
BE2017C055I2 (fr)
BE2017C051I2 (fr)
BE2017C032I2 (fr)
BE2016C051I2 (fr)
FR08C0024I2 (fr)
BE2017C050I2 (fr)
JP2002080162A5 (fr)
JP2002200039A5 (fr)
CH1379220H1 (fr)
BRPI0204884A2 (fr)
JP2002048342A5 (fr)
JP2002210742A5 (fr)
BE2017C059I2 (fr)
BRPI0101486B8 (fr)
JP2002032035A5 (fr)
JP2001243063A5 (fr)
JP2002154209A5 (fr)
BRPI0210463A2 (fr)
JP2001351120A5 (fr)
AU2000280389A8 (fr)
JP2002108494A5 (fr)
JP2002245129A5 (fr)
JP2002224843A5 (fr)